Collectively, these data demonstrate that HDAC3 promotes hPASMC proliferation under hypoxia through the CSF2-mediated activation of the JAK2/STAT5 signaling pathway, implicating this axis in the vascular remodeling process observed in PAH. The gene discussed is HDAC3; the disease is pulmonary arterial hypertension.